What do systematic reviews say?

Angiotensin‐converting enzyme inhibitors vs placebo

• Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 34 participants
  Low

Angiotensin‐converting enzyme inhibitors vs placebo

• Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 14 participants
  Low

Angiotensin‐converting enzyme inhibitors vs placebo

The review found no eligible studies for this question.

• Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Angiotensin‐converting enzyme inhibitors vs placebo

Angiotensin‐converting enzyme inhibitors showed no clear difference in adverse events (4 to 6‐week compared with placebo (low certainty).

• Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
  RR 1.35 [0.67, 2.73]
  3 studies · 46 participants
  Low

Angiotensin‐converting enzyme inhibitors vs placebo

The review found no eligible studies for this question.

• Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Motivational interviewing intensive (MII) vs motivational interviewing (MI) to reduce alcohol consumption

• Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 163 participants
  Low
• Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 163 participants
  Low
• Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 163 participants
  Low

Motivational interviewing intensive (MII) vs motivational interviewing (MI) to reduce alcohol consumption

Motivational interviewing intensive (MII) may leads to higher retention ‐ end of treatment compared with motivational interviewing (MI) to reduce alcohol consumption (low certainty).

• Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users 2018 · Cochrane Headline outcomes only
  RR 17.63 [1.03, 300.48]
  1 study · 163 participants
  Low

Intensive discharge planning and case management vs prison only

Intensive discharge planning and case management showed no clear difference in marijuana use compared with prison only (moderate certainty).

• Interventions for female drug‐using offenders 2019 · Cochrane Headline outcomes only
  RR 0.79 [0.53, 1.16]
  1 study · 511 participants
  Moderate

Intensive discharge planning and case management vs prison only

Intensive discharge planning and case management showed no clear difference in hard drug use compared with prison only (moderate certainty).

• Interventions for female drug‐using offenders 2019 · Cochrane Headline outcomes only
  RR 1.12 [0.88, 1.43]
  1 study · 511 participants
  Moderate

Intensive discharge planning and case management vs prison only

Intensive discharge planning and case management showed no clear difference in positive hair test for crack cocaine compared with prison only (moderate certainty).

• Interventions for female drug‐using offenders 2019 · Cochrane Headline outcomes only
  OR 1.08 [0.75, 1.54]
  1 study · 511 participants
  Moderate

Intensive discharge planning and case management vs prison only

Intensive discharge planning and case management showed no clear difference in positive hair test for marijuana use compared with prison only (moderate certainty).

• Interventions for female drug‐using offenders 2019 · Cochrane Headline outcomes only
  RR 0.75 [0.55, 1.03]
  1 study · 511 participants
  Moderate

Intensive discharge planning and case management vs prison only

Intensive discharge planning and case management probably leads to lower arrested compared with prison only (moderate certainty).

• Interventions for female drug‐using offenders 2019 · Cochrane Headline outcomes only
  RR 0.19 [0.04, 0.87]
  1 study · 511 participants
  Moderate

Intensive discharge planning and case management vs prison only

Intensive discharge planning and case management showed no clear difference in drug charge compared with prison only (moderate certainty).

• Interventions for female drug‐using offenders 2019 · Cochrane Headline outcomes only
  RR 1.07 [0.75, 1.53]
  1 study · 511 participants
  Moderate

Intensive discharge planning and case management vs prison only

Intensive discharge planning and case management showed no clear difference in incarceration compared with prison only (moderate certainty).

• Interventions for female drug‐using offenders 2019 · Cochrane Headline outcomes only
  RR 1.09 [0.86, 1.39]
  1 study · 511 participants
  Moderate

TENS vs anticholinergics

It is very uncertain whether transcutaneous electrical nerve stimulation (TENS) changes resolution of daytime urinary incontinence at 3 months compared with anticholinergics (very low certainty).

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  RR 0.81 [0.05, 12.5]
  2 studies · 72 participants
  Very low

TENS vs anticholinergics

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 44 participants
  Very low

TENS vs anticholinergics

The review found no eligible studies for this question.

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

TENS vs anticholinergics

The review found no eligible studies for this question.

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

TENS vs anticholinergics

The review found no eligible studies for this question.

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

TENS vs anticholinergics

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 61 participants
  Very low